With support from the National Institute on Drug Abuse and the Substance Abuse and Mental Health Services Administration, the National Academies of Sciences, Engineering, and Medicine convened an expert committee to examine the evidence base for medications to treat OUD and to identify barriers that prevent people from accessing safe, effective, medication-based treatment. The resulting report, Medications for Opioid Use Disorder Save Lives, presents the committee’s findings and conclusions.
The Intersection of Behavioral Health, Mental Health, and Health Literacy
The purpose of the workshop, which was held on July 11, 2018, in Washington, DC, was to explore issues associated with effective communication with individuals with mental or behavioral health issues and to identify ways in which health literacy approaches can facilitate communication. In particular, the workshop aimed to gain a better understanding of how behavioral health and mental health concerns can adversely affect communications between providers and patients and their families. This publication summarizes the presentations and discussions from the workshop.
Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities
This article discusses the benefits of mobilizing the PCP workforce to offer addiction treatment with buprenorphine, and tackles the stigma and myths that still act as barriers to physicians adopting buprenorphine treatment.